These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4500669)

  • 1. Platelet and fibrinogen kinetics with ( 75 Se)-selenomethionine in patients with myeloproliferative disorders.
    Brodsky I; Ross EM; Petkov G; Kahn SB
    Br J Haematol; 1972 Feb; 22(2):179-92. PubMed ID: 4500669
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
    Brodsky I; Kahn SB; Ross EM; Petkov G
    Cancer; 1972 Dec; 30(6):1444-50. PubMed ID: 4509103
    [No Abstract]   [Full Text] [Related]  

  • 3. Dysplastic platelets and circulating megakaryocytes in chronic myeloproliferative diseases. I. The platelets: ultrastructure and peroxidase reaction.
    Maldonado JE; Pintado T; Pierre RV
    Blood; 1974 Jun; 43(6):797-809. PubMed ID: 4524752
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders.
    Okuma M
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1139-44. PubMed ID: 6800179
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
    Tangün Y
    Thromb Diath Haemorrh; 1971 Jun; 25(2):241-51. PubMed ID: 5284903
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet defects in the myeloproliferative disorders.
    Inceman S; Tangün Y
    Ann N Y Acad Sci; 1972 Oct; 201():251-61. PubMed ID: 4509685
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: Role of the megakaryocyte and platelet in the leukemic process in mice and men--a review and hypothesis.
    Brodsky I
    J Natl Cancer Inst; 1973 Aug; 51(2):329-35. PubMed ID: 4358128
    [No Abstract]   [Full Text] [Related]  

  • 8. Megakaryocytes in cubital venous blood in patients with chronic myeloproliferative diseases.
    Tinggaard Pedersen N; Laursen B
    Scand J Haematol; 1983 Jan; 30(1):50-8. PubMed ID: 6573016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets in the myeloproliferative syndrome.
    Weinfeld A; Branehög I; Kutti J
    Clin Haematol; 1975 Jun; 4(2):373-92. PubMed ID: 1102193
    [No Abstract]   [Full Text] [Related]  

  • 10. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
    Murphy S; Davis JL; Walsh PN; Gardner FH
    Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet 5-hydroxytryptamine transport and storage in myeloproliferative disorders.
    Cortellazzo S; Viero P; Buczko W; Barbui T; de Gaetano G
    Scand J Haematol; 1985 Feb; 34(2):146-51. PubMed ID: 3856312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (51Cr)platelet kinetics in thrombocytopenia. Correlation between splenic sequestration of platelets and response to splenectomy.
    Ries CA; Price DC
    Ann Intern Med; 1974 Jun; 80(6):702-7. PubMed ID: 4524870
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurement of platelet life-span in normal subjects and patients with myeloproliferative disease with indium oxine labelled platelets.
    Bautista AP; Buckler PW; Towler HM; Dawson AA; Bennett B
    Br J Haematol; 1984 Dec; 58(4):679-87. PubMed ID: 6240280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Granulocyte clearance and granulocyte kinetics in myeloproliferative syndromes].
    Jungi WF; Meuret G; Senn HJ
    Schweiz Med Wochenschr; 1974 Jan; 104(4):133-5. PubMed ID: 4521299
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet and fibrinogen kinetics in healthy and African swine fever-affected swine: [75Se]selenomethionine-labeling study.
    Edwards JF; Dodds WJ
    Am J Vet Res; 1985 Jan; 46(1):181-4. PubMed ID: 3970425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet and fibrinogen kinetics with ( 75 Se)selenomethionine in thrombocytopenic states. II.
    Brodsky I; Ross EM; Kahn SB; Petkov G
    Br J Haematol; 1972 May; 22(5):589-98. PubMed ID: 5032097
    [No Abstract]   [Full Text] [Related]  

  • 17. Spontaneous platelet aggregation in myeloproliferative disorders. A preliminary study.
    Barbui T; Battista R; Dini E
    Acta Haematol; 1973; 50(1):25-9. PubMed ID: 4200801
    [No Abstract]   [Full Text] [Related]  

  • 18. Myelofibrosis and rapid thrombocytolysis. A case report.
    Kutti J; Bergström AL; Ridell B
    Acta Med Scand; 1977; 201(3):249-55. PubMed ID: 848365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
    Viero P; Cortelazzo S; Bassan R; Barbui T
    Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet survival, platelet factor-4 and bleeding time in myeloproliferative disorders.
    Berild D; Hasselbalch H; Knudsen JB
    Scand J Clin Lab Invest; 1987 Sep; 47(5):497-501. PubMed ID: 3477851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.